CPJE key terms

The California state agency that licenses pharmacists and pharmacies, adopts regulations, and enforces the Pharmacy Law through inspections, investigations, and disciplinary action.

The body of California statutes and Board regulations governing pharmacy practice, including the Business and Professions Code pharmacy provisions and Title 16 of the California Code of Regulations.

The licensed pharmacist designated by a pharmacy to be responsible for its overall operation, including compliance with law, recordkeeping, security, and supervision of personnel.

The limit on how many certified or licensed pharmacy technicians one pharmacist may supervise at a given time, which varies with the practice setting and the technician's licensure status.

A person registered or licensed by the Board to assist a pharmacist with non-discretionary tasks such as data entry, counting, labeling, and stock management under pharmacist supervision.

A pharmacy student or graduate registered with the Board who gains supervised practice hours toward licensure and may perform pharmacist duties only under direct pharmacist supervision.

The credential issued by the Board authorizing a person to practice pharmacy in California after meeting education, examination, and internship requirements, renewable on a set cycle.

The minimum number of approved education hours a licensee must complete during each renewal period, including any mandated topic hours such as law and patient safety.

A licensee's legal duty to notify the Board within a specified time after certain events, such as arrest, conviction, or disciplinary action by another licensing authority.

A formal notice of an alleged violation issued by the Board that may carry fines or orders of abatement and can be contested through an administrative appeal process.

A restricted license that allows practice under specified conditions and monitoring imposed by the Board as a disciplinary outcome instead of outright revocation.

The mandated information a pharmacy must print on a dispensed prescription container, including patient name, drug name and strength, directions, quantity, prescriber, pharmacy, and required cautions.

The minimum period a pharmacy must keep prescription and dispensing records on file and readily retrievable for inspection by the Board and other authorized agencies.

A pharmacist's required offer of verbal consultation to a patient or caregiver about a new or changed prescription, covering proper use, storage, and significant risks.

The prescriber's permission allowing a pharmacy to dispense additional supplies of a prescription, which must be documented and limited by the original order.

The process of moving an active prescription from one pharmacy to another, requiring pharmacist-to-pharmacist communication and documentation of the transfer details.

The federal registration required for a pharmacy or practitioner to handle controlled substances, which must be current before dispensing or ordering such drugs.

The federal and state classification of drugs by abuse potential and accepted medical use, which determines prescribing, dispensing, refill, and recordkeeping rules.

The California prescription drug monitoring database that pharmacists and prescribers query to review a patient's history of controlled substance dispensing.

A risk-management program requiring periodic white blood cell monitoring for patients taking clozapine, with dispensing restricted until results are confirmed and documented.

A FDA-required safety program for certain drugs that may restrict dispensing, require patient or prescriber certification, or mandate specific counseling and monitoring.

Any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of a health care professional or patient.

A pharmacy's required systematic process for detecting, documenting, analyzing, and preventing medication errors and improving dispensing accuracy over time.

The practices and systems designed to prevent medication errors and adverse drug events, including verification, labeling, counseling, and error reporting.

The process of comparing a patient's current medication list with new orders to identify discrepancies, omissions, duplications, or interactions at transitions of care.

A pharmacist-delivered service that reviews a patient's medications to optimize outcomes, improve adherence, and reduce adverse events, often provided under a collaborative agreement.

A written agreement between a pharmacist and prescriber authorizing the pharmacist to initiate, adjust, or discontinue drug therapy under defined conditions and protocols.

The legal ability to authorize drug therapy, which pharmacists may exercise only within specific statutory exceptions or under a valid collaborative or protocol arrangement.

The preparation, mixing, or altering of a drug product to meet a specific patient's needs, subject to standards for equipment, ingredients, personnel training, and quality assurance.

Preparation of sterile products such as injectable or ophthalmic dosage forms, requiring controlled environments, validated processes, and specialized training and testing.

Nationally recognized compounding and quality standards, including general chapters on nonsterile and sterile preparation, that California pharmacies must follow.

The date after which a dispensed or compounded preparation should not be used, determined from stability data and the conditions under which it is stored.

A structured review of a patient's drug therapy to screen for interactions, duplications, dosing problems, and appropriateness before or after dispensing.

An injury or harm resulting from a medication, including adverse reactions, errors, and overdoses, which should be identified and managed to protect the patient.

The final check by a pharmacist confirming that a prepared prescription matches the prescriber's order in drug, strength, quantity, labeling, and directions before dispensing.

A drug with a heightened risk of significant harm when used in error, requiring extra safeguards such as independent double checks and distinctive labeling.

Medications whose names or packaging are easily confused, a common source of dispensing errors that warrants special storage, labeling, and verification precautions.

The measures a pharmacy must maintain to prevent theft, diversion, or unauthorized access, including locked storage of controlled substances and limited key access.